<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38530">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01948622</url>
  </required_header>
  <id_info>
    <org_study_id>Mulungu-401-2011</org_study_id>
    <nct_id>NCT01948622</nct_id>
  </id_info>
  <brief_title>Anxiety Control by Erythrina Mulungu</brief_title>
  <official_title>Anxiety Control by Using Erythrina Mulungu in Mandibular Third Molars Extraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liane Maciel de Almeida Souza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal de Sergipe</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluated the effectiveness of the Erythrina mulungu in controlling anxiety in
      patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      : In this research, characterized as a randomized, double-blind, crossover study, 30 healthy
      volunteered patients (05 men and 25 women) aged 18 or older who received a capsule of 500mg
      of Mulungu Matusa ® or placebo, orally, one hour before the procedure were selected. The
      level of anxiety was assessed through questionnaires and physical parameters, such as blood
      pressure, heart rate and oxygen concentration. Data were collected, tabulated and analyzed
      by the following statistical tests: chi-square, t-test, ANOVA and Tukey test, Friedman,
      Fisher's exact test with significance level of 5%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Changes in anxiety report</measure>
    <time_frame>Change from baseline to 7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes in the  subjects' anxiety level was observed by using a Modified Corah Dental Anxiety Scale in three times: at baseline, in the day of surgery and after 7 days of the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>Change from baseline to 2 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>blood pressure (mmHg) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate</measure>
    <time_frame>Change from baseline to 2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>heart rate (bpm) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in oxygen saturation</measure>
    <time_frame>Change from baseline to 2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>oxygen saturation (SpO2) was measured before drug administration, 30 minutes after drug administration and during local anesthesia, incision, tooth removal and suturing.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Dental Anxiety</condition>
  <condition>Impacted Third Molar Tooth</condition>
  <arm_group>
    <arm_group_label>Mulungu</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500 mg Mulungu Matusa® (Erytrina mulungu, 2 capsules of 250 mg) administered v.o., one hour before the surgical procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>500 mg of starch (2 capsules of 250 mg) administered v.o., one hour before the surgical procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mulungu</intervention_name>
    <description>500 mg/single dose/1 hour before dental surgery</description>
    <arm_group_label>Mulungu</arm_group_label>
    <other_name>Mulungu Matusa, Erytrina mulungu</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>500 mg/single dose/1 hour before dental surgery</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication of bilateral extraction of asymptomatic, impacted mandibular third molars

        Exclusion Criteria:

          -  patients under the age of 18

          -  any general health problem based on the medical history and physical examination

          -  history of use of any medication within 15 days before the beginning of the research

          -  history of hypersensitivity to drugs, substances or materials used in this experiment

          -  pregnancy or lactation

          -  history of pericoronitis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liane M Souza, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sergipe</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal University of Sergipe</name>
      <address>
        <city>Aracaju</city>
        <state>Sergipe</state>
        <zip>49060-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Balbani AP, Silva DH, Montovani JC. Patents of drugs extracted from Brazilian medicinal plants. Expert Opin Ther Pat. 2009 Apr;19(4):461-73. doi: 10.1517/13543770902824180. Review.</citation>
    <PMID>19441926</PMID>
  </reference>
  <reference>
    <citation>Flausino OA Jr, Pereira AM, da Silva Bolzani V, Nunes-de-Souza RL. Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety. Biol Pharm Bull. 2007 Feb;30(2):375-8.</citation>
    <PMID>17268084</PMID>
  </reference>
  <reference>
    <citation>Flausino O Jr, Santos Lde A, Verli H, Pereira AM, Bolzani Vda S, Nunes-de-Souza RL. Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu. J Nat Prod. 2007 Jan;70(1):48-53.</citation>
    <PMID>17253849</PMID>
  </reference>
  <reference>
    <citation>Onusic GM, Nogueira RL, Pereira AM, Flausino Júnior OA, Viana Mde B. Effects of chronic treatment with a water-alcohol extract from Erythrina mulungu on anxiety-related responses in rats. Biol Pharm Bull. 2003 Nov;26(11):1538-42.</citation>
    <PMID>14600397</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 18, 2013</lastchanged_date>
  <firstreceived_date>September 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Sergipe</investigator_affiliation>
    <investigator_full_name>Liane Maciel de Almeida Souza</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Anxiety</keyword>
  <keyword>Third molar surgery</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Heart rate</keyword>
  <keyword>Oxygen saturation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Tooth, Impacted</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
